Cholinesterase inhibitor use does not significantly influence the ability of (123)I‐FP‐CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies

BACKGROUND: (123)I‐labelled 2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane ((123)I‐FP‐CIT) imaging is a diagnostic tool to help differentiate dementia with Lewy bodies (DLB) from Alzheimer's disease (AD). However, in animals, cholinesterase inhibitors (ChEi) have been reported...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Taylor, John‐Paul, Colloby, Sean J, McKeith, Ian G, Burn, David J, Williams, David, Patterson, Jim, O'Brien, John T
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2117542/
https://ncbi.nlm.nih.gov/pubmed/17299017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.2006.111666
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados